← Home
🚀 Sign up Free for Public Company Valuation & Insights!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free Video Highlights
Astellas Pharma
-4.42%
Pharma / Pharmaceuticals, Healthcare
At a Glance | Core Facts | Company Due Diligence: | Industry Due Diligence: | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebCore Facts
CEO | Mr. Naoki Okamura BSc |
Employees | 14754 |
Phone | 81 3 3244 3000 |
Address | 2-5-1, Nihonbashi-Honcho Tokyo 0103-8411 JP |
IPO Date | 2009-12-29 |
Average Volumes | 188654 |
Market Cap | 16.451 bil USD |
Div >7% since | N/A |
Web | https://www.astellas.com/en/ |
ISIN | JP3942400007 |
NASDAQ ticker | ALPMY |
News on YouTube | YouTube |
SEC | 'Astellas Pharma' on SEC |
Reports | 'Astellas Pharma' Reports |
CUSIP | 04623U102 |
Wait! There's more — sign up for free or log in